Persistent efficacy of tumor necrosis factor alpha blockage therapy in SAPHO syndrome: comment on the article by Wagner et al.
Ignazio
I
Olivieri
Angela
A
Padula
Giovanni
G
Ciancìo
Carlo
C
Salvarani
Laura
L
Niccoli
Fabrizio
F
Cantini
D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000037:antagonists & inhibitors*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018124:Receptors, Tumor Necrosis Factor; D000069285:Infliximab